No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites-Reference-Cited by-同舟云学术

No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites

Published:2019-01-02 Issue:5 Volume:42 Page:720-728
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Ronald James,Rao Rajiv,Choi Steven S.,Kappus Matthew,Martin Jonathan G.,Sag Alan A.,Pabon-Ramos Waleska M.,Suhocki Paul V.,Smith Tony P.,Kim Charles Y.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00270-018-02155-9.pdf

Reference28 articles.

1. Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, Kallwitz ER, et al. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol JVIR. 2013;24(3):411–20. https://doi.org/10.1016/j.jvir.2012.10.026 20.e1-4; quiz 21.

2. Ronald J, Wang Q, Choi SS, Suhocki PV, Hall MD, Smith TP, et al. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation. Diagn Interv Imaging. 2018;99(3):163–8. https://doi.org/10.1016/j.diii.2017.10.008 .

3. Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004;231(1):231–6. https://doi.org/10.1148/radiol.2311030967 .

4. Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. J Vasc Interv Radiol JVIR. 2005;16(4):449–55. https://doi.org/10.1097/01.rvi.0000149508.64029.02 .

5. Pan JJ, Chen C, Caridi JG, Geller B, Firpi R, Machicao VI, et al. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years’ experience from a single tertiary medical center. J Vasc Interv Radiol JVIR. 2008;19(11):1576–81. https://doi.org/10.1016/j.jvir.2008.07.021 .

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long term impact of transjugular intrahepatic portosystemic shunt (TIPS) creation on hepatic morphology;Clinical Imaging;2024-06

2. Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting;Journal of Clinical Medicine;2024-01-21

3. Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison;World Journal of Gastroenterology;2022-11-07

4. Transjugular intrahepatic portosystemic shunt for the treatment of refractory ascites: A population-based cohort study;Canadian Liver Journal;2020-11

5. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update;World Journal of Gastroenterology;2020-10-07